Showing results (191-200 of 215) with videos related to
Sort By:
Pageof 22
Journal of Translational Medicine|March 23, 2024
Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axisYang Yang, Huaifeng Li, Ke Liu, et al.Cancer Letters|January 2, 2017
Whole-genome sequencing reveals the mutational landscape of metastatic small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC)Maolan Li, Fatao Liu, Yijian Zhang, et al.Nature Communications|April 2, 2022
Single-cell and spatial analysis reveal interaction of FAP<sup>+</sup> fibroblasts and SPP1<sup>+</sup> macrophages in colorectal cancerJingjing Qi, Hongxiang Sun, Yao Zhang, et al.Nature Communications|April 14, 2026
Rational design of a Kappa opioid receptor peptide agonist with attenuated β-arrestin signalingHuanhuan Zhang, Ruolan Wang, Pan Shi, et al.BMC Cancer|September 30, 2024
Mutational signatures in 175 Chinese gastric cancer patientsFatao Liu, Nan Hu, Kewei Jiang, et al.Cancer Letters|January 23, 2016
LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathwayZhiZhen Li, YuanYuan Chen, XuAn Wang, et al.Cancer Letters|March 8, 2016
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growthYijian Zhang, Shibo Liu, Lei Wang, et al.Signal Transduction and Targeted Therapy|February 13, 2025
Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicingZiyi Wang, Li Gao, Ziheng Jia, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 4, 2024
Super-Enhancer Reprograming Driven by SOX9 and TCF7L2 Represents Transcription-Targeted Therapeutic Vulnerability for Treating Gallbladder CancerSiyuan Yan, Zhaonan Liu, Teng Wang, et al.Ebiomedicine|March 1, 2022
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancerXiaofei Zhang, Tiebo Mao, Bei Zhang, et al.Pageof 22